Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

VEGFR2/KDR/CD309 Antibody

" in MedChemExpress (MCE) Product Catalog:

標的別:	VEGFR (6)
研究分野別:	Cancer (3) Inflammation/Immunology (3)

阻害剤およびアゴニスト

阻害性抗体

抗体

Targets Recommended:

製品番号	製品名	Target	研究分野	構造式

HY-P990543

*Anti-VEGFR2/KDR/CD309* Antibody (AT001)**	VEGFR	Inflammation/Immunology
The Anti-VEGFR2/KDR/CD309 Antibody (AT001) is a humanized antibody expressed in CHO cells that targets *VEGFR2/KDR/CD309. The Anti-VEGFR2/KDR/CD309* Antibody (AT001) contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for the Anti-VEGFR2/KDR/CD309 Antibody (AT001) can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990542

Anti-VEGFR2/KDR/CD309 Antibody	VEGFR	Inflammation/Immunology
Anti-VEGFR2/KDR/CD309 Antibody is a humanized antibody expressed in CHO, targeting *VEGFR2/KDR/CD309. The Anti-VEGFR2/KDR/CD309* Antibody is equipped with muIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-VEGFR2/KDR/CD309 Antibody, refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991420

UB-925	VEGFR	Cancer
UB-925 is a human monoclonal antibody (mAb) targeting *VEGFR2/KDR/CD309*. UB-925 can be used in Gastric cancer research .

HY-P991689

Girancitug	VEGFR	Cancer
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor targeting VEGFR2/KDR/CD309. Girancitug effectively inhibits angiogenesis. Girancitug can be used for anti-angiogenic therapy in cancers like colorectal and ovarian cancer research .

HY-P991419

MSB-0254	VEGFR	Cancer
MSB-0254 is a human monoclonal antibody (mAb) targeting *VEGFR2/KDR/CD309. MSB-0254 inhibits the invasion, migration, and vascular mimetic (VM) formation of U251 and primary glioma cells. MSB-0254 inhibits the growth of U251 and GL261 cell transplanted tumors. MSB-0254 reduces the expression of CD34, VEGFR2*, Ki67, MMP2, MMP9, and CD34/PAS. MSB-0254 can be used in advanced solid tumors research .

HY-P990318

Alacizumab	VEGFR	Inflammation/Immunology
Alacizumab is a CHO-expressed humanized antibody that targets *VEGFR2/KDR/CD309*. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

製品番号	製品名	Target	研究分野	Image

HY-P990543

*Anti-VEGFR2/KDR/CD309* Antibody (AT001)**	VEGFR	Inflammation/Immunology
The Anti-VEGFR2/KDR/CD309 Antibody (AT001) is a humanized antibody expressed in CHO cells that targets *VEGFR2/KDR/CD309. The Anti-VEGFR2/KDR/CD309* Antibody (AT001) contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for the Anti-VEGFR2/KDR/CD309 Antibody (AT001) can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990542

Anti-VEGFR2/KDR/CD309 Antibody	VEGFR	Inflammation/Immunology
Anti-VEGFR2/KDR/CD309 Antibody is a humanized antibody expressed in CHO, targeting *VEGFR2/KDR/CD309. The Anti-VEGFR2/KDR/CD309* Antibody is equipped with muIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-VEGFR2/KDR/CD309 Antibody, refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991420

UB-925	VEGFR	Cancer
UB-925 is a human monoclonal antibody (mAb) targeting *VEGFR2/KDR/CD309*. UB-925 can be used in Gastric cancer research .

HY-P991689

Girancitug	VEGFR	Cancer
Girancitug is a humanized IgG1κ monoclonal antibody inhibitor targeting VEGFR2/KDR/CD309. Girancitug effectively inhibits angiogenesis. Girancitug can be used for anti-angiogenic therapy in cancers like colorectal and ovarian cancer research .

HY-P991419

MSB-0254	VEGFR	Cancer
MSB-0254 is a human monoclonal antibody (mAb) targeting *VEGFR2/KDR/CD309. MSB-0254 inhibits the invasion, migration, and vascular mimetic (VM) formation of U251 and primary glioma cells. MSB-0254 inhibits the growth of U251 and GL261 cell transplanted tumors. MSB-0254 reduces the expression of CD34, VEGFR2*, Ki67, MMP2, MMP9, and CD34/PAS. MSB-0254 can be used in advanced solid tumors research .

HY-P990318

Alacizumab	VEGFR	Inflammation/Immunology
Alacizumab is a CHO-expressed humanized antibody that targets *VEGFR2/KDR/CD309*. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Host:	Mouse (1) Rabbit (2)
Reactivity:	Human (3) Rat (1) Mouse (2) Fish (1)
Application:	IHC-P (2) ICC/IF (3) IP (1) IHC-F (1) WB (3) ChIP (1) FC (1) ELISA (3)
Isotype:	IgG (2)
Conjugation:	Non-conjugated (3)
Clonality:	Polyclonal (1) Monoclonal (2)
Modification:	Unmodified (3)

製品番号	Compare	製品名	Application	Reactivity	Image

HY-P81643

	VEGF Receptor 2 Antibody 2 Publications Verification KDR; FLK1; VEGFR2; Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD antigen CD309	WB, IHC-P, IHC-F, ICC/IF, ELISA	Human, Mouse
	VEGF Receptor 2 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to VEGF Receptor 2.

HY-P85168

	VEGF Receptor 2 Antibody (YA4860) KDR; FLK1; VEGFR2; Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD antigen CD309	WB, ChIP, ICC/IF, FC, ELISA	Human, Fish
	VEGF Receptor 2 Antibody (YA4860) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to VEGF Receptor 2.

HY-P86118

	VEGF Receptor 2 Antibody (YA5810) Vascular endothelial growth factor receptor 2; VEGFR-2; Fetal liver kinase 1; FLK-1; Kinase insert domain receptor; KDR; Protein-tyrosine kinase receptor flk-1; CD antigen CD309;	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	VEGF Receptor 2 Antibody (YA5810) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to VEGF Receptor 2.

Compare Products


Products	在庫あり - + カートに追加
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / 在庫あり - + カートに追加お問い合わせ

オンラインお問い合わせ

入力情報は安全に管理されます. ※ 必須入力項目.

日本の代理先をお選びくださいナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
タイトル			国或いは地域 *
お名前 *			組纖名 *
デパートメント *
メールアドレス *			製品名 *
製品番号			カスタマ需要量 *
電話番号 *
必ず会社名を記載ください。個人への返信は行いません。
備考

バルクお問い合わせ

Inquiry Information

製品名:
製品番号:
数量:
MCE 日本正規代理店:

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature. Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non-fat milk in TBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (Beta Actin, HY-P80438, 1/10000) was used in 5% non-fat milk in TBST at 4°C overnight. Goat Anti-Mouse/Rabbit IgG-HRP Secondary Antibody (1/10000) was used for 1 hour at room temperature.

BODIPY 493/503 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Feb 1;16(1):1241. [Abstract]

MedchemExpress Validation 01

MedchemExpress Validation 03

Western blot analysis of extracts from THP-1(lane 2(20μg), Jurkat (lane 3(20μg) and NIH3T3(lane 4(20μg) using FOXO1A (HY-P80132) Rabbit mAb. Proteins were transferred

MedchemExpress Validation 04

MedchemExpress Validation

We use cookies

MedChemExpress values your privacy and your trust is important to us. We use cookies to enhance your website experience. Some cookies are necessary to run the website. Privacy and Cookie Policy

お名前
メール *

	Sorry, but the email address you supplied was invalid.